What is the Impact of Price Controls on Patients And

Others With a Stake in the Healthcare Debate? / Major Study Examines Implications for Europe, Japan and the U.S. Washington, D.C. (PROTEXT) - WHAT: Warner-Lambert will release findings of a study, conducted by The Boston Consulting Group (BCG), measuring the impact of price controls on the three stakeholders in the health care debate: patients, government and companies. WHEN: Thursday, April 29 12:00 Noon -- 2:00 PM WHERE: National Press Club First Amendment Room 529 14th Street, N.W. Washington, D.C. WHO: Dr. Anthony H. Wild, President, Pharmaceutical Sector, Warner-Lambert Company Arnon A. Mishkin, Vice President, Boston Consulting Group Simon J. Goodall, Project Leader, Boston Consulting Group WHY: In Japan, the U.S. and several countries in Europe, debate continues to rage over health care reform. This important study will provide valuable information and analysis for those policy debates. RSVP TO: Lisa Knapp -- 202-548-0602 Editors Note: A Video News Release and copies of the study will be available. Following their presentations, the participants will be available to answer questions. ots Original Text Service: Warner-Lambert Company Internet: http://www.newsaktuell.de CONTACT: Steve Selby, 202-548-0601, for Warner-Lambert Company. Subscribers please note that material bearing the slug "PROTEXT" is not part of CTK's news service and is not to be published under the "CTK" slug. Protext is a commercial service providing distribution of press releases from clients, who are identified in the text of Protext reports and who bear full responsibility for their contents. PROTEXT